T tthya
Search Pricing API
Log in
Sign up
K
COMPANY U21000TS2024FTC184449 Active Foreign-subsidiary

KRKA PHARMA PRIVATE LIMITED

CIN U21000TS2024FTC184449 · ROC TS · est. 2024 · paid-up ₹2150000000 · Manufacturing (Metals and Chemicals, and products thereof) · Unlisted

stub — full data not yet fetched

2 yrs old 8 active dirs

We don't have full data on this company yet

Click below and we'll fetch it from MCA. Usually completes in under five minutes. Free; no payment required to request a fetch.

Current directors (8)

Showing 5 of 8

Name DIN Designation Appointed Status
Director 10769960 CEO 23/07/2024 Active
Director 10590234 Director 12/04/2024 Active
Director 00211921 Non- Individual Subscriber 12/04/2024 Active
Director 01424180 Director 12/04/2024 Active
Director 10590236 Non- Individual Subscriber 12/04/2024 Active
+ 3 more current directors — sign up free to see history

See every director who has served on the board of KRKA PHARMA PRIVATE LIMITED, including ceased and resigned. Free signup, no card required.

Sign up free →
+ 1 ceased — sign up free to see history

See former directors, cessation dates, and board-history changes for KRKA PHARMA PRIVATE LIMITED.

Sign up free →

Address

map preview

2nd Floor SDE Serene,Chambers Road No 7,Khairatabad,Hyderabad,Telangana,500034-India

Filings (0)

No filings on file.

Charges (0)

No charges on file. (coverage rolling out)

Group structure

3 related entities via shared directors and addresses.

Try Pro free — group traversal included →

Alerts

Get notified when KRKA PHARMA PRIVATE LIMITED appoints or loses a director, files a charge, changes its registered address, or enters strike-off / IBC.

Stub record

Full report is fetched on demand. Click Request full report above and the data lands in a few minutes.

Pro

  • • Group structure (related-party traversal)
  • • Co-director graph for every director here
  • • Watchlist & alerts on this CIN
  • • CSV / PDF export of the full report
Try Pro 7 days free →

For developers

GET /v1/companies/U21000TS2024FTC184449

Docs →
More actions